Net shares · 90d
-69.0K
0 buy · 69.0K sell
Net value · 90d
-$1.8M
$0 in · $1.8M out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
12
0 buy · 69.0K sell
Net buy / sell volume (all companies)
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions · open-market
Include grants & non-market-
MLYS Sell·S
Chief Medical Officer · 10b5-1
$114.6K
4.6K sh · $25.00
Own -7%
-
MLYS Sell·S
Chief Medical Officer · 10b5-1
$235.5K
9.9K sh · $23.81
Own -15%
-
MLYS Sell·S
Chief Medical Officer · 10b5-1
$151.9K
6.3K sh · $23.93
Own -9%
-
MLYS Sell·S
Chief Medical Officer · 10b5-1
$54.2K
2.2K sh · $25.00
Own -3%
-
MLYS Sell·S
Chief Medical Officer · 10b5-1
$11.5K
417 sh · $27.55
Own -1%
-
MLYS Sell·S
Chief Medical Officer · 10b5-1
$401.8K
14.1K sh · $28.58
Own -18%
-
MLYS Sell·S
Chief Medical Officer · 10b5-1
$186.3K
6.3K sh · $29.36
Own -8%
-
MLYS Sell·S
Chief Medical Officer · 10b5-1
$64.5K
2.2K sh · $29.71
Own -3%
-
MLYS Sell·S
Chief Medical Officer · 10b5-1
$13.0K
416 sh · $31.33
Own -1%
-
MLYS Sell·S
Chief Medical Officer · 10b5-1
$175.6K
6.3K sh · $27.66
Own -8%
-
MLYS Sell·S
Chief Medical Officer · 10b5-1
$373.1K
14.1K sh · $26.54
Own -16%
-
MLYS Sell·S
Chief Medical Officer · 10b5-1
$59.4K
2.2K sh · $27.38
Own -3%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | MLYS | Sell S | 4.6K | $114.6K |
| Jun 15, 2026 | MLYS | Sell S | 9.9K | $235.5K |
| Jun 12, 2026 | MLYS | Sell S | 6.3K | $151.9K |
| Jun 10, 2026 | MLYS | Sell S | 2.2K | $54.2K |
| May 18, 2026 | MLYS | Sell S | 417 | $11.5K |
| May 13, 2026 | MLYS | Sell S | 14.1K | $401.8K |
| May 12, 2026 | MLYS | Sell S | 6.3K | $186.3K |
| May 11, 2026 | MLYS | Sell S | 2.2K | $64.5K |
| Apr 17, 2026 | MLYS | Sell S | 416 | $13.0K |
| Apr 15, 2026 | MLYS | Sell S | 6.3K | $175.6K |
| Apr 13, 2026 | MLYS | Sell S | 14.1K | $373.1K |
| Apr 9, 2026 | MLYS | Sell S | 2.2K | $59.4K |
About David Malcom Rodman
This profile aggregates every SEC Form 4 insider transaction reported by David Malcom Rodman across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.